Literature DB >> 35064864

Prognostic value of modified National Institute of Health activity and chronicity scoring in determining complete renal response in newly diagnosed lupus nephritis: a retrospective single centre study.

Shivendra Singh1, H C Sreenidhi2.   

Abstract

INTRODUCTION: Early response to therapy is associated with favourable long-term outcome in LN. The working group of revision of ISN/RPS classification guidelines for LN recommended modified National Institute of Health (NIH) activity and chronicity scoring system to evaluate active and chronic lesions. Data on usefulness of modified NIH scoring system to determine complete renal response (CR) in LN are sparse.
METHODS: We retrospectively studied 80 LN patients diagnosed from June/2018 to April/2020, who has followed up for more ≥ 6 months in our hospital. CR was defined by inactive urinary sediment, urine PCR of 0.5 g/g in a 24 h urine collection and normalization/stabilization of renal function. Pathologic lesions were described as per revised 2018 ISN/RPS classification and the modified NIH scoring system. Patients were grouped by AI (low, 0-5; moderate, 6-11; high, 12-24) and CI (low, 0-2; moderate, 3-5; high, 6-12). Time to event was analysed using Kaplan-Meier curves. Prognostic variables for CR were analysed by multivariable Cox proportional hazard models.
RESULTS: With a median follow-up of 8 months, 50 patients (62.5%) achieved CR. Kaplan-Meier curves showed lower CR with high AI groups (p value = 0.001) and moderate/high CI groups (p value < 0.001). Moderate and high CI with HR of 0.088 (0.034-0.229) p value < 0.001 and Glomerulosclerosis Score with HR of 0.155 (0.072-0.331) p value < 0.001 were significant determinant of CR.
CONCLUSION: Moderate and high CI scores were associated with lower chances of CR in LN. Glomerulosclerosis of CI was significant determinant of CR.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Complete renal response; Lupus nephritis; Modified NIH indices; SLE

Mesh:

Year:  2022        PMID: 35064864     DOI: 10.1007/s11255-022-03112-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  15 in total

1.  Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.

Authors:  Frédéric A Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; Renato Alberto Sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Journal:  Arthritis Rheum       Date:  2004-12

2.  Lupus Nephritis Class IV-Global Is Associated with a Higher Risk of End-Stage Renal Disease than Class IV-Segmental.

Authors:  Camila Oliveira; Henrique Mariz; Gisele Fernandes; Denise Costa; Maria Alina Cavalcante; Lucila Valente
Journal:  Nephron       Date:  2020-01-07       Impact factor: 2.847

3.  Interobserver agreement on histopathological lesions in class III or IV lupus nephritis.

Authors:  Suzanne Wilhelmus; H Terence Cook; Laure-Hélène Noël; Franco Ferrario; Ron Wolterbeek; Jan A Bruijn; Ingeborg M Bajema
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-10       Impact factor: 8.237

4.  The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese.

Authors:  Hitoshi Yokoyama; Takashi Wada; Akinori Hara; Junya Yamahana; Izaya Nakaya; Motoo Kobayashi; Kiyoki Kitagawa; Satoshi Kokubo; Yasunori Iwata; Keiichi Yoshimoto; Kazuaki Shimizu; Norihiko Sakai; Kengo Furuichi
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

5.  Survival analysis and causes of mortality in patients with lupus nephritis.

Authors:  Desmond Y H Yap; Colin S O Tang; Maggie K M Ma; Man Fai Lam; Tak Mao Chan
Journal:  Nephrol Dial Transplant       Date:  2012-04-20       Impact factor: 5.992

6.  Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization.

Authors:  G B Appel; D J Cohen; C L Pirani; J I Meltzer; D Estes
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

Review 7.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

8.  Value of a complete or partial remission in severe lupus nephritis.

Authors:  Yiann E Chen; Stephen M Korbet; Robert S Katz; Melvin M Schwartz; Edmund J Lewis
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

9.  Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus.

Authors:  C C Mok; Raymond C L Kwok; Paul S F Yip
Journal:  Arthritis Rheum       Date:  2013-08

10.  Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV.

Authors:  Hironari Hanaoka; Harunobu Iida; Tomofumi Kiyokawa; Yukiko Takakuwa; Kimito Kawahata
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.